NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from Dankang BioHealth? Mail in a sample (US only) and let us test it.

Test my supply
+10 more ↓
71%
Finnrick rating
#251 of 281 Tirzepatide vendors
7 of 11 classifiable tests passed
natural 64% · customers 4.9★ (13)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Dankang BioHealth's Tirzepatide score is pulled down by repeated identity failures and a +87% quantity result, not routine purity misses. A later 60 mg test recovered with 99.99% purity and -7% fill, leaving a mixed trajectory.

methodology →
vendor intelligence report
Vendor Intelligence Report: Dankang BioHealth

Corporate claims, late-domain records and a same-template storefront cluster do not line up cleanly. The report traces broken/working COA links, rotating sales personas, Facebook funnels, parasite-SEO pages and payment-recourse gaps.

41 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
86%
7
2
Retatrutide
$0.80
77%
35
3
Tirzepatideselected
$0.49
71%
11
4
SS-31
$0.75
66%
3
5
KLOW
$0.33
65%
3
6
BPC-157
$0.67
52%
7
7
Tesamorelin
$2.14
51%
9
8
TB-500
$1.52
38%
6
9
CJC-1295
$4.00
30%
3
10
MOTS-c
$0.78
29%
6
11
NAD+
$0.01
28%
6
12
5-Amino-1MQ
$0.67
-
0
13
Epithalon
$0.33
-
0
14
Glutathione
$0.01
-
0
15
Ipamorelin
$1.24
-
0
16
KPV
$0.63
-
0
17
Semax
$0.59
-
0
18
VIP
$1.82
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%22 Jan 2026: 81%13 Feb 2026: 81%2 Mar 2026: 77%2 Mar 2026: 78%25 Mar 2026: 73%28 Apr 2026: 75%28 Apr 2026: 76%30 Apr 2026: 77%6 May 2026: 73%17 Jun 2026: 70%2 Nov 2026: 72%15 Nov 2026: current 71%81%73%71%Jan 26Nov 26
Showing Tirzepatide tests only
Dankang BioHealth Tirzepatide test history
COA-backed lab tests
1-10 of 11

About Dankang BioHealth test results from Finnrick

Dankang BioHealth is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 96 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Dankang BioHealth peptides in this dataset are BPC-157 (7 tests), CJC-1295 (3 tests) and GHK-Cu (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 96 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tirzepatide from Dankang BioHealth? Mail in a sample (US only) and let us test it.

Test my supply